Publication | Closed Access

A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice

New VaccineBone Morphogenic ProteinUnnatural Amino AcidImmunologyOsteoarthritisVaccine DesignMedicineCell BiologyOsteoporosisOsteocalcinOvx-induced Bone Loss